TY - JOUR
T1 - National patterns in human papillomavirus vaccination
T2 - An analysis of the national survey of family growth
AU - Sadigh, Gelareh
AU - Dempsey, Amanda F.
AU - Ruffin IV, Mack T.
AU - Resnicow, Ken
AU - Carlos, Ruth C.
N1 - Funding Information:
the respondents’ adolescent daughters; and (3) maternal intent to Since June 2009, A.F.D. has served as an advisory board mem-vaccinate her daughter against HPV in the next 12 mo if no dose ber for Merck, providing advice on male HPV vaccination. This had been previously received. The likelihood of future adoles-company had no role in the design or analysis of this study, and is cent HPV vaccination was as a dichotomous outcome by defin-unaware of the study’s results. R.C.C. is a member of physician’s ing “intent to vaccinate” as those who responded they were “very advisory board of Phillips. Mack Ruffin is supported by a grant likely” or “somewhat likely” to have their daughter vaccinated, from the National Cancer Institute CA080846. Gelareh Sadigh and no intent to vaccinate as those responding they were “not too and Ken Resnicow have no conflict of interest to declare. likely” and “not likely at all” to have their daughter vaccinated.
PY - 2012/2
Y1 - 2012/2
N2 - Human papillomavirus (HPV) vaccine has shown effectiveness for girls and young women. Despite this, there are population disparities in vaccine utilization rates. The purpose of this study was to evaluate maternal correlates of HPV vaccination among their adolescent daughters using a nationally-representative population-based sample, emphasizing race/ethnicity-specific disparities and barriers. Mothers of 9-18 y-old girls having heard of HPV vaccine and completing the HPV vaccine survey module from the 2006-2008 National Survey of Family Growth (NSFG) (n = 444) were analyzed for maternally-reported adolescent HPV vaccination and maternal intent to vaccinate her adolescent daughter if no dose had been received. Correlates of uptake and intent were examined using multivariate logistic regression. 27% of mothers (n = 98) reported that their daughters were vaccinated against HPV. Independent correlates of vaccination included African-American race (adjusted odds ratio (AOR),0.29; 95% confidence interval (CI),0.11-0.77), and living below the poverty level (AOR,4.43; 95%CI, 1.53-12.82). 46% (n = 152) of mothers of non-vaccinated daughters intended to vaccinate them. Correlates of maternal intention included maternal pelvic exam history (AOR,0.06; 95%CI, 0.007-0.51), multiple male lifetime sexual partners (AOR,3.22 ; 95% CI, 1.34-7.76), religiosity (AOR,0.37; 95% CI,0.16-0.87) and acceptability of premarital sex among 18 y-olds (AOR,2.45; 95% CI, 1.16-5.20). In conclusion, HPV vaccination initiation among adolescent daughters of mothers participating in the NSFG continues to lag among African-American participants. However, no racial/ethnic differences in maternal intent-to-vaccinate her daughter were detected. Future interventions need to address specific maternal barriers to vaccine uptake and how these may differ from vaccine intention.
AB - Human papillomavirus (HPV) vaccine has shown effectiveness for girls and young women. Despite this, there are population disparities in vaccine utilization rates. The purpose of this study was to evaluate maternal correlates of HPV vaccination among their adolescent daughters using a nationally-representative population-based sample, emphasizing race/ethnicity-specific disparities and barriers. Mothers of 9-18 y-old girls having heard of HPV vaccine and completing the HPV vaccine survey module from the 2006-2008 National Survey of Family Growth (NSFG) (n = 444) were analyzed for maternally-reported adolescent HPV vaccination and maternal intent to vaccinate her adolescent daughter if no dose had been received. Correlates of uptake and intent were examined using multivariate logistic regression. 27% of mothers (n = 98) reported that their daughters were vaccinated against HPV. Independent correlates of vaccination included African-American race (adjusted odds ratio (AOR),0.29; 95% confidence interval (CI),0.11-0.77), and living below the poverty level (AOR,4.43; 95%CI, 1.53-12.82). 46% (n = 152) of mothers of non-vaccinated daughters intended to vaccinate them. Correlates of maternal intention included maternal pelvic exam history (AOR,0.06; 95%CI, 0.007-0.51), multiple male lifetime sexual partners (AOR,3.22 ; 95% CI, 1.34-7.76), religiosity (AOR,0.37; 95% CI,0.16-0.87) and acceptability of premarital sex among 18 y-olds (AOR,2.45; 95% CI, 1.16-5.20). In conclusion, HPV vaccination initiation among adolescent daughters of mothers participating in the NSFG continues to lag among African-American participants. However, no racial/ethnic differences in maternal intent-to-vaccinate her daughter were detected. Future interventions need to address specific maternal barriers to vaccine uptake and how these may differ from vaccine intention.
UR - http://www.scopus.com/inward/record.url?scp=84858168578&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84858168578&partnerID=8YFLogxK
U2 - 10.4161/hv.18456
DO - 10.4161/hv.18456
M3 - Article
C2 - 22414967
AN - SCOPUS:84858168578
SN - 2164-5515
VL - 8
SP - 234
EP - 242
JO - Human Vaccines and Immunotherapeutics
JF - Human Vaccines and Immunotherapeutics
IS - 2
ER -